TA

Thukkaram Ashokraj Lakshmi Narasiman

Active Director Director DIN 11314528
DIN 11314528 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Thukkaram Ashokraj Lakshmi Narasiman

Data last updated:

Thukkaram Ashokraj Lakshmi Narasiman is a Director at Takk India Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11314528
Primary Designation Director
Industry Pharma
First Appointment 24 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Sep 20252025Active

Board colleagues of Thukkaram Ashokraj Lakshmi Narasiman

Directorship timeline

Open interactive timeline →
Takk India Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Thukkaram Ashokraj Lakshmi Narasiman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thukkaram Ashokraj Lakshmi Narasiman

Thukkaram Ashokraj Lakshmi Narasiman currently holds 1 directorship: Takk India Pharmaceuticals Private Limited (Director, since 24 Sep 2025).

Thukkaram Ashokraj Lakshmi Narasiman was first appointed on 24 Sep 2025 as Director at Takk India Pharmaceuticals Private Limited.

The current boards of Thukkaram Ashokraj Lakshmi Narasiman's companies include Kumaresan Bagavathiappan (Takk India Pharmaceuticals Private Limited), Ramesh (Takk India Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available